Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

PubWeight™: 65.36‹?› | Rank: Top 0.01% | All-Time Top 1000

🔗 View Article (PMC 2707599)

Published in PLoS Med on July 21, 2009

Authors

David Moher1, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman, PRISMA Group

Author Affiliations

1: Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. dmoher@ohri.ca

Articles citing this

(truncated to the top 100)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 7.15

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88

Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol (2015) 5.57

Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 5.34

Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (2014) 5.33

Malaria resurgence: a systematic review and assessment of its causes. Malar J (2012) 5.11

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res (2013) 4.78

The long-term health consequences of child physical abuse, emotional abuse, and neglect: a systematic review and meta-analysis. PLoS Med (2012) 4.37

The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research. Implement Sci (2012) 4.15

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med (2010) 4.13

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis (2014) 4.09

Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr (2013) 3.83

Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies. PLoS Med (2011) 3.60

Evidence-based clinical guidelines for immigrants and refugees. CMAJ (2010) 3.57

Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry (2015) 3.56

Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol (2014) 3.45

Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet (2015) 3.38

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet (2014) 3.38

Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ (2011) 3.35

Interventions with family caregivers of cancer patients: meta-analysis of randomized trials. CA Cancer J Clin (2010) 3.23

Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality. J Stud Alcohol Drugs (2016) 3.19

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ (2011) 3.17

Mental health and psychosocial support in humanitarian settings: linking practice and research. Lancet (2011) 3.16

Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis. BMJ (2015) 3.01

B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology (2013) 2.98

Negative-pressure wound therapy: systematic review of randomized controlled trials. Dtsch Arztebl Int (2011) 2.97

A systematic review of re-identification attacks on health data. PLoS One (2011) 2.91

The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev (2012) 2.86

Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol (2012) 2.85

Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83

Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials. BMJ (2010) 2.83

World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol (2013) 2.83

The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med (2013) 2.80

Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One (2014) 2.75

Are health behavior change interventions that use online social networks effective? A systematic review. J Med Internet Res (2014) 2.67

Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med (2014) 2.60

Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. Clin Infect Dis (2012) 2.60

An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev (2011) 2.59

Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ (2013) 2.56

Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One (2012) 2.55

Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis. PLoS Negl Trop Dis (2012) 2.54

Fecal contamination of drinking-water in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med (2014) 2.50

The protective role of coastal marshes: a systematic review and meta-analysis. PLoS One (2011) 2.49

Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis (2012) 2.49

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis (2015) 2.40

Bridges, brokers and boundary spanners in collaborative networks: a systematic review. BMC Health Serv Res (2013) 2.40

Clarifying differences between review designs and methods. Syst Rev (2012) 2.39

Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis. Bull World Health Organ (2010) 2.37

Community health workers and mobile technology: a systematic review of the literature. PLoS One (2013) 2.36

Water, sanitation, hygiene, and soil-transmitted helminth infection: a systematic review and meta-analysis. PLoS Med (2014) 2.35

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33

Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act (2015) 2.31

PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med (2012) 2.31

A review of online evidence-based practice point-of-care information summary providers. J Med Internet Res (2010) 2.31

Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open (2013) 2.30

Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis (2013) 2.30

Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol (2015) 2.29

Infection Risk in Sterile Operative Procedures. Dtsch Arztebl Int (2016) 2.27

De novo erectile dysfunction after anterior urethroplasty: a systematic review and meta-analysis. BJU Int (2013) 2.27

Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. Ann Oncol (2013) 2.27

A systematic review of the surgical treatment of large incisional hernia. Hernia (2014) 2.26

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ (2013) 2.26

Meta-analysis and systematic review of laparoscopic versus open mesh repair for elective incisional hernia. Hernia (2015) 2.23

The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep (2013) 2.22

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18

Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis. PLoS Med (2011) 2.18

Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One (2014) 2.17

Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ (2016) 2.17

Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care (2012) 2.16

Efficacy of low-level laser therapy in the management of orthodontic pain: a systematic review and meta-analysis. Lasers Med Sci (2012) 2.15

Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med (2011) 2.14

Maternal depression and early childhood growth in developing countries: systematic review and meta-analysis. Bull World Health Organ (2011) 2.13

CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother (2010) 2.13

The use of google trends in health care research: a systematic review. PLoS One (2014) 2.12

The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Rep (2013) 2.11

Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol (2013) 2.10

Health outcomes during the 2008 financial crisis in Europe: systematic literature review. BMJ (2016) 2.08

Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health (2015) 2.08

Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol (2013) 2.08

613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med (2012) 2.07

A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health (2013) 2.04

Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod (2013) 2.04

Evaluation of the accuracy of patient-specific cutting blocks for total knee arthroplasty: a meta-analysis. Int Orthop (2014) 2.03

Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann Fam Med (2012) 2.03

The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis (2013) 1.99

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med (2013) 1.98

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophr Bull (2011) 1.98

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96

Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. PLoS Med (2016) 1.94

A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med (2014) 1.93

Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis (2015) 1.93

Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (2012) 1.93

Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis (2014) 1.93

Articles cited by this

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet (1999) 37.76

The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet (2004) 18.69

Replication validity of genetic association studies. Nat Genet (2001) 16.30

Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy (2005) 12.22

The medical review article: state of the science. Ann Intern Med (1987) 11.57

Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA (1994) 10.80

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75

Meta-analyses of randomized controlled trials. N Engl J Med (1987) 10.37

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ (2001) 9.63

Clinical trial registration: a statement from the International Committee of Medical Journal Editors. CMAJ (2004) 8.52

The case of the misleading funnel plot. BMJ (2006) 8.26

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87

Putting clinical trials into context. Lancet (2005) 7.29

Systematic reviews of evaluations of prognostic variables. BMJ (2001) 6.69

Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA (2002) 5.87

Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med (1995) 5.48

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Meta-analyses in orthopaedic surgery. A systematic review of their methodologies. J Bone Joint Surg Am (2001) 4.98

Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90

Number of published systematic reviews and global burden of disease: database analysis. BMJ (2003) 4.53

Systematic reviews: when is an update an update? Lancet (2006) 4.51

A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care (2005) 4.51

Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ (2006) 4.36

Evaluating the quality of systematic reviews in the emergency medicine literature. Ann Emerg Med (2001) 4.16

Meta-analysis: an update. Mt Sinai J Med (1996) 4.06

Value judgments in the analysis and synthesis of evidence. J Clin Epidemiol (2008) 3.58

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis. Ann Intern Med (2001) 3.49

Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews. Anesth Analg (2001) 3.48

The quality of systematic reviews in dentistry. Evid Based Dent (2004) 3.27

Articles by these authors

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92

Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30

CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87

Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80

Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51

Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43

Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98

Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46

Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39

Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25

SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21

Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86

Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55

Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47

Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43

Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33

Going from evidence to recommendations. BMJ (2008) 7.30

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61

Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55

Reporting recommendations for tumor marker prognostic studies. J Clin Oncol (2005) 6.31

The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ (2010) 5.70

Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58

No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57

Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat (2007) 5.52

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ (2009) 5.45

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ (2005) 5.36

The design of simulation studies in medical statistics. Stat Med (2006) 5.30

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98

Ghost authorship in industry-initiated randomised trials. PLoS Med (2007) 4.95

Quantification of the completeness of follow-up. Lancet (2002) 4.77

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA (2012) 4.73

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49

Prognosis and prognostic research: what, why, and how? BMJ (2009) 4.46

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ (2010) 4.46

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43